Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Sherman

Showing results (41-50 of 154) with videos related to

Pageof 16
Sort By:
JHEP Reports : Innovation in Hepatology|March 21, 2020
The second volumeMorris Sherman
JHEP Reports : Innovation in Hepatology|February 11, 2020
Editorial musingsMorris Sherman
JHEP Reports : Innovation in Hepatology|February 11, 2020
How to improve HCC surveillance outcomesMorris Sherman
Clinics in Liver Disease|October 16, 2004
Pathogenesis and screening for hepatocellular carcinomaMorris Sherman
Hepatology (Baltimore, Md.)|June 18, 2005
Diagnosis of small hepatocellular carcinomaMorris Sherman
Seminars in Liver Disease|May 27, 2005
Hepatocellular carcinoma: epidemiology, risk factors, and screeningMorris Sherman
Hepatology (Baltimore, Md.)|December 6, 2012
Whither hepatocellular carcinoma screening?Morris Sherman
Best Practice & Research. Clinical Gastroenterology|September 28, 2014
Surveillance for hepatocellular carcinomaMorris Sherman
Hepatology (Baltimore, Md.)|October 24, 2017
Regorafenib for treatment of hepatocellular carcinomaMorris Sherman
Seminars in Liver Disease|July 28, 2021
Assessing Toxicity in Drug Trials in Liver DiseaseMorris Sherman
Pageof 16

Showing results (41-50 of 154) with videos related to

Sort By:
Pageof 16
JHEP Reports : Innovation in Hepatology|March 21, 2020
The second volumeMorris Sherman
JHEP Reports : Innovation in Hepatology|February 11, 2020
Editorial musingsMorris Sherman
JHEP Reports : Innovation in Hepatology|February 11, 2020
How to improve HCC surveillance outcomesMorris Sherman
Clinics in Liver Disease|October 16, 2004
Pathogenesis and screening for hepatocellular carcinomaMorris Sherman
Hepatology (Baltimore, Md.)|June 18, 2005
Diagnosis of small hepatocellular carcinomaMorris Sherman
Seminars in Liver Disease|May 27, 2005
Hepatocellular carcinoma: epidemiology, risk factors, and screeningMorris Sherman
Hepatology (Baltimore, Md.)|December 6, 2012
Whither hepatocellular carcinoma screening?Morris Sherman
Best Practice & Research. Clinical Gastroenterology|September 28, 2014
Surveillance for hepatocellular carcinomaMorris Sherman
Hepatology (Baltimore, Md.)|October 24, 2017
Regorafenib for treatment of hepatocellular carcinomaMorris Sherman
Seminars in Liver Disease|July 28, 2021
Assessing Toxicity in Drug Trials in Liver DiseaseMorris Sherman
Pageof 16